148901-09-1

Basic information

• Product Name: 4-iodo-N-(thiazol-2-yl)benzenesulfonamide
• Synonyms: 4-iodo-N-(thiazol-2-yl)benzenesulfonamide
• CAS NO: 148901-09-1
• Molecular Weight: 366.203
• Mol File: 148901-09-1.mol

Chemical Properties

• CAS DataBase Reference: 4-iodo-N-(thiazol-2-yl)benzenesulfonamide(CAS DataBase Reference)
• NIST Chemistry Reference: 4-iodo-N-(thiazol-2-yl)benzenesulfonamide(148901-09-1)
• EPA Substance Registry System: 4-iodo-N-(thiazol-2-yl)benzenesulfonamide(148901-09-1)

Safety Data

• Hazardous Substances Data: 148901-09-1(Hazardous Substances Data)

Upstream product

• 72-14-0 Sulfathiazole 
• 96-50-4 2-thiazolylamine 
• 98-61-3 p-Iodobenzenesulfonyl chloride 

Downstream Products

• 1063732-15-9 4-({(2S)-2-[(3-chlorophenoxy)methyl]pyrrolidin-1-yl}carbonyl)-N-1,3-thiazol-2-ylbenzenesulfonamide 
• 1063732-17-1 N-{2-[(4-chlorophenyl)amino]ethyl}-4-[(1,3-thiazol-2-ylamino)sulfonyl]benzamide 
• 1063732-93-3 N-(3,3-dimethylbutyl)-4-[(1,3-thiazol-2-ylamino)sulfonyl]benzamide 
• 1063732-19-3 4-[(1,3-thiazol-2-ylamino)sulfonyl]-N-(2-thienylmethyl)benzamide 
• 1104803-63-5 4-(1-(3-chloro-4-fluorophenyl)-4-cyano-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104807-00-2 2-(3-(4-chlorobenzyl)-5-(4-(N-thiazol-2-ylsulfamoyl)phenylamino)-1H-pyrazol-1-yl)acetic acid 
• 1104803-55-5 4-(3-(4-Chlorobenzyl)-1-methyl-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104803-42-0 4-(1-tert-butyl-3-(4-chlorobenzyl)-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104803-57-7 4-(1,3-di-tert-butyl-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104803-49-7 4-(5-tert-butylisoxazol-3-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104803-53-3 4-(3-methyl-1-phenyl-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 
• 1104803-47-5 4-(3-Tert-butyl-1-methyl-1H-pyrazol-5-ylamino)-N-(thiazol-2-yl)benzenesulfonamide 

Relevant articles and documents

Direct Transformation of Arylamines to Aryl Halides via Sodium Nitrite and N-Halosuccinimide

A one-pot universal approach for transforming arylamines to aryl halides via reaction with sodium nitrite (NaNO2) and N-halosuccinimide (NXS) in DMF at room temperature under metal- and acid-free condition is described. This new protocol that is complementary to the Sandmeyer reaction, is suggested to involve the in situ generation of nitryl halide induce nitrosylation of aryl amine to form the diazo intermediate which is halogenated to furnish the aryl halide.

SODIUM CHANNEL INHIBITORS

Compounds, compositions and methods are provided which are useful in the treatment of diseases through the inhibition of sodium ion flux through voltage-gated sodium channels. More particularly, the invention provides substituted sulfonamides, composition

HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS

The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.

HETEROCYCLIC DERIVATIVES AS MODULATORS OF ION CHANNELS

The present invention relates to heterocyclic derivatives useful as inhibitors of ion channels. The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various disorders.